TALMedora Editorial
HSV-1 Has Been Infecting Humans Since the Beginning of…
HSV-1 Has Been Infecting Humans Since the Beginning of Time. No vaccine. No cure. No end in sight. Until now, there may finally be a path forward. A groundbreaking mathematical modelling study published in Science Advances just gave the clearest picture yet of what an HSV-1 vaccine could actually achieve. And the numbers are staggering. With 70% vaccine efficacy and lifelong protection, infant vaccination alone could: Reduce oral HSV-1 infections by nearly 50%. Reduce genital HSV-1 infections by nearly 60%. Avert approximately 28.5 million infections by 2075. Add adolescent catch-up vaccination and that number jumps to 41.8 million infections averted. Why genital HSV-1 specifically matters right now: Most doctors still think of HSV-1 as the cold sore virus. But the epidemiology has shifted dramatic
Create an account to read the full story.
Join TALMedora to get full access
Already have an account?
Comments (0)
No comments yet. Be the first to comment!